Quantum BioPharma is trading 5.6% higher at $3.00 in pre-market as the stock stages a technical rebound after several days of selling pressure.
- The move follows a recent slide that pushed shares below the $3.00 level, with the current strength appearing to be a modest bounce amid a generally firmer equity tone.
- No fresh company-specific headlines, earnings, FDA decisions, or major analyst calls have been tied directly to the price action.